Peripheral nervous system manifestations of lyme borreliosis

Journal of Clinical Neuromuscular Disease

Volumn 3, Issue 4, 2002, Pages 165-171

  Thaisetthawatkul, Pariwat ^a   Logigian, Eric L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIUM ANTIBODY; CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE; GLUCOSE; PENICILLIN G; PROTEIN; TETRACYCLINE;

BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; CHOLECYSTITIS; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRANIAL NEUROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ERADICATION THERAPY; FACIAL NERVE PARALYSIS; FEVER; HEADACHE; HUMAN; LYME DISEASE; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; MUSCLE WEAKNESS; NERVE FIBER DEGENERATION; NEURITIS; NEUROLOGICAL COMPLICATION; PATHOGENESIS; PERIPHERAL NEUROPATHY; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMEMBRANOUS COLITIS; RADICULAR PAIN; REVIEW; SENSORY DYSFUNCTION; SERODIAGNOSIS; TREATMENT OUTCOME;

EID: 0036049419     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131402-200206000-00006     Document Type: Review

References (82)

1. Lyme disease: A tick-borne spirochetosis?
2. Lyme neuroborreliosis
3. Neurologic abnormalities of Lyme disease
4. Nervous system abnormalities in Lyme disease
5. Borrelia burgdorferi in the nervous system: The new great imitator
6. Peripheral nervous system Lyme borreliosis
7. Neuroborreliosis
8. Chroniche lymphozytare Meningitis, entzundliche Polyneuritis und Rheumatismus
9. Paralysie par les tiques
10. Tick-borne meningo-polyneuritis (Garin-Bujadoux, Bannwarth)
11. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990
12. The triad of neurologic manifestations of Lyme disease: Meningitis, cranial neuritis, and radiculoneuritis
13. Lyme borreliosis
14. Clinical characteristic and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans
15. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum
16. Respiratory failure due to Lyme meningoradiculitis
17. Acute Lyme neuropathy presenting with polyradicular pain, abdominal protrusion, and cranial neuropathy
18. Lyme polyradiculoneuropathy presenting as increasing abdominal girth
19. Neurologic manifestations in children with North American Lyme disease
20. Neurologic manifestations in children with Lyme disease
21. Meningo-radiculitis due to borreliosis presenting as low back pain only
22. Facial paralysis in Lyme disease
23. Polyneuritis cranialis associated with Borrelia burgdorferi
24. Polyneuritis cranialis in Lyme disease
25. Lyme disease
26. Lyme disease with acute purulent meningitis
27. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis
28. Chronic neurologic manifestations of Lyme disease
29. Clinical and electrophysiologic findings in chronic neuropathy in Lyme disease
30. Lyme disease: Cause of a treatable peripheral neuropathy
31. Neuropathy associated with acrodermatitis chronica atrophicans
32. Peripheral neuropathy in acrodermatitis chronica atrophicans-a late Borrelia manifestation
33. Polyneuropathy in late Lyme borreliosis-a clinical, neurophysiological and morphological description
34. Lyme borreliosis
35. Nervous system Lyme borreliosis-revisited
36. Clinical guideline 2: Laboratory evaluation in the diagnosis of Lyme disease
37. Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease
38. Early disseminated Lyme disease: Lyme meningitis
39. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease
40. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis
41. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in patients with Lyme neuroborreliosis
42. The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis
43. False-positive results of PCR testing for Lyme disease
44. Death from inappropriate therapy for Lyme disease
45. The diagnosis of Lyme disease: Good news, bad news
46. Intralaboratory reliability of serologic and urine testing for Lyme disease
47. Case definition for public health surveillance
48. Clinical guideline part 1: Guideline for laboratory evaluation in the diagnosis of Lyme disease
49. Neurological aspects of Lyme disease
50. Lyme disease
51. Peripheral neuropathies after arthropod stings not due to Lyme disease: A report of five cases and review of the literature
52. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis
53. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome)
54. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis
55. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis
56. Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples form patients with early and late Lyme neuroborreliosis by polymerase chain reaction
57. Tick-bite meningoradiculoneuritis: Clinical, electrophysiologic, and histologic findings in 10 cases
58. Cranial nerve involvement with Lyme borreliosis demonstrated by magnetic resonance imaging
59. Lyme neuroborreliosis. Peripheral nervous system manifestation
60. Carpal tunnel syndrome in Lyme borreliosis
61. Peripheral nerve disorders in Lyme-borreliosis. Nerve biopsy studies from eight cases
62. Detection of Borrelia burgdorferi DNA and complement membrane attack complex deposits in the sural nerve of a patient with chronic polyneuropathy and tertiary Lyme disease
63. Localization of Borrelia burgdorferi in the nervous system and other organs in a non-human primate model of Lyme disease
64. A rabbit model of Lyme neuroborreliosis: Characterization by PCR, serology, and sequencing of the OspA gene from the brain
65. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: The early disseminated and chronic phases of disease in the peripheral nervous system
66. Mononeuropathy multiplex with chronic Lyme disease
67. Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis
68. Lyme disease: A review of aspects of its immunology and immunopathogenesis
69. Host-pathogen interactions in the immunopathogenesis of Lyme disease
70. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein
71. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis
72. Monoclonal antibodies for identification of Borrelia afzelii sp. Nov. associated with late cutaneous manifestations of Lyme borreliosis
73. Etiology of acrodermatitis chronica atrophicans lesion in Lyme disease
74. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America
75. Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis
76. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease
77. Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis
78. Neurologic abnormalities of Lyme disease: Successful treatment with high dose intravenous penicillin
79. Comparison of intravenous penicillin G and oral doxycycline for treatment of neurologic Lyme disease
80. Persistent painful Lyme radiculoneuritis
81. Prognosis in facial palsy in Borrelia burgdorferi meningopolyradiculoneuritis
82. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease